Abbvie Inc
NYSE: ABBV
$193.47
-$0.15 (-0.1%)
Closing Price on September 20, 2024
ABBV Articles
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
Published:
Last Updated:
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
Published:
Last Updated:
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
Published:
Last Updated:
AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Published:
Last Updated:
These four Jefferies Franchise Picks are rated Buy and pay the highest dividends. They make good sense for investors now.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital should still focus on top dividend-paying stocks.
Published:
Last Updated:
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.
Published:
Last Updated: